Literature DB >> 30214878

Stephen Y. Chan: perseverance through criticism is essential for success in cardiovascular research.

Brad Li.   

Abstract

Year:  2018        PMID： 30214878      PMCID： PMC6129834          DOI： 10.21037/cdt.2018.08.02

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  7 in total

1.  Matrix Remodeling Promotes Pulmonary Hypertension through Feedback Mechanoactivation of the YAP/TAZ-miR-130/301 Circuit.

Authors:  Thomas Bertero; Katherine A Cottrill; Yu Lu; Christina M Haeger; Paul Dieffenbach; Sofia Annis; Andrew Hale; Balkrishen Bhat; Vivek Kaimal; Ying-Yi Zhang; Brian B Graham; Rahul Kumar; Rajan Saggar; Rajeev Saggar; W Dean Wallace; David J Ross; Stephen M Black; Sohrab Fratz; Jeffrey R Fineman; Sara O Vargas; Kathleen J Haley; Aaron B Waxman; B Nelson Chau; Laura E Fredenburgh; Stephen Y Chan
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

2.  Network medicine--from obesity to the "diseasome".

Authors:  Albert-László Barabási
Journal:  N Engl J Med       Date:  2007-07-25       Impact factor: 91.245

Review 3.  Network medicine: a network-based approach to human disease.

Authors:  Albert-László Barabási; Natali Gulbahce; Joseph Loscalzo
Journal:  Nat Rev Genet       Date:  2011-01       Impact factor: 53.242

4.  Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension.

Authors:  Thomas Bertero; William M Oldham; Katherine A Cottrill; Sabrina Pisano; Rebecca R Vanderpool; Qiujun Yu; Jingsi Zhao; Yiyin Tai; Ying Tang; Ying-Yi Zhang; Sofiya Rehman; Masataka Sugahara; Zhi Qi; John Gorcsan; Sara O Vargas; Rajan Saggar; Rajeev Saggar; W Dean Wallace; David J Ross; Kathleen J Haley; Aaron B Waxman; Victoria N Parikh; Teresa De Marco; Priscilla Y Hsue; Alison Morris; Marc A Simon; Karen A Norris; Cedric Gaggioli; Joseph Loscalzo; Joshua Fessel; Stephen Y Chan
Journal:  J Clin Invest       Date:  2016-08-22       Impact factor: 14.808

5.  MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.

Authors:  Stephen Y Chan; Ying-Yi Zhang; Craig Hemann; Christopher E Mahoney; Jay L Zweier; Joseph Loscalzo
Journal:  Cell Metab       Date:  2009-10       Impact factor: 27.287

6.  Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.

Authors:  Kevin White; Yu Lu; Sofia Annis; Andrew E Hale; B Nelson Chau; James E Dahlman; Craig Hemann; Alexander R Opotowsky; Sara O Vargas; Ivan Rosas; Mark A Perrella; Juan C Osorio; Kathleen J Haley; Brian B Graham; Rahul Kumar; Rajan Saggar; Rajeev Saggar; W Dean Wallace; David J Ross; Omar F Khan; Andrew Bader; Bernadette R Gochuico; Majed Matar; Kevin Polach; Nicolai M Johannessen; Haydn M Prosser; Daniel G Anderson; Robert Langer; Jay L Zweier; Laurence A Bindoff; David Systrom; Aaron B Waxman; Richard C Jin; Stephen Y Chan
Journal:  EMBO Mol Med       Date:  2015-06       Impact factor: 12.137

7.  Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.

Authors:  Thomas Bertero; Yu Lu; Sofia Annis; Andrew Hale; Balkrishen Bhat; Rajan Saggar; Rajeev Saggar; W Dean Wallace; David J Ross; Sara O Vargas; Brian B Graham; Rahul Kumar; Stephen M Black; Sohrab Fratz; Jeffrey R Fineman; James D West; Kathleen J Haley; Aaron B Waxman; B Nelson Chau; Katherine A Cottrill; Stephen Y Chan
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 19.456
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.